Video

How Vaccines Are Made and Manufactured: Viral Vector Platform

Viral vector-based vaccines constitute a promising part of the biopharmaceutical pipeline, addressing many unmet indications. Some estimates show that half of the front runners of vaccine candidates for COVID-19 have used the viral vector platform. Moreover this is a complex platform with more than 40 vectors being used for both gene therapy and vaccines. Watch this video to learn how vaccines are manufactured using a viral-vector platform.

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: